CLC Number:
- R473.55
| [1] 王昱, 黄晓军. 造血干细胞移植在血液疾病中的应用进展[J]. 中华血液学杂志, 2019, 40(8):704-708.DOI:10.3760/cma.j.issn.0253-2727.2019.08.020. [2] Elad S, Raber-Durlacher JE, Brennan MT, et al.Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the Joint Task Force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)[J]. Support Care Cancer, 2015,23(1):223-236.DOI:10.1007/s00520-014-2378-x. [3] 贾灵芝, 李小丽, 王凤然. 2015版“MASCC/ISOO/EBMT放化疗及造血干细胞移植者口腔护理专家共识”解读[J]. 护理研究, 2018, 32(2):167-168. DOI:10.3969/j.issn.1009-6493.2018.02.001. [4] Aromataris E, Fernandez R, Godfrey CM, et al.Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach[J]. Int J Evid Based Healthc,2015, 13(3):132-140.DOI:10.1097/xeb.0000000000000055. [5] Shea BJ, Reeves BC, Wells G, et al.AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both[J]. BMJ, 2017, 358:j4008. DOI:10.1136/bmj.j4008. [6] Brouwers MC, Kho ME, Browman GP, et al.AGREE II: advancing guideline development, reporting and evaluation in health care[J]. CMAJ, 2010, 182(18):E839-842.DOI:10.1503/cmaj.090449. [7] The Joanna Briggs Institute. JBI’s critical appraisal tools assist in assessing the trustworthiness, relevance and results of published papers[EB/OL]. (2017-11-24)[2020-06-13]. https://jbi.global/critical-appraisal-tools. [8] 刘云访, 喻姣花, 李素云, 等. ICU成人患者气管插管非计划性拔管预防及管理的证据总结[J]. 护理学报, 2020, 27(3):43-48. DOI:10.16460/j.issn1008-9969.2020.03.043. [9] 王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967. [10] Peterson DE, Boers-Doets CB, Bensadoun RJ, et al.Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up[J]. Ann Oncol, 2015, 26(Suppl 5):v139-151. DOI:10.1093/annonc/mdv202. [11] Hong CHL, Gueiros LA, Fulton JS, et al.Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines[J]. Support Care Cancer, 2019, 27(10):3949-3967. DOI:10.1007/s00520-019-04848-4 [12] Navdeep K, Mary B,Anthony B,et al.The oral management of oncology patients requiring radiotherapy, chemotherapy and/or bone marrow transplantation[J].Faculty Dental Journal, 2019, 85:1-85. [13] Zadik Y, Arany PR, Fregnani ER, et al.Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines[J]. Support Care Cancer,2019,27(10):3969-3983.DOI:10.1007/s00520-019-04890-2. [14] Correa MEP, Cheng KKF, Chiang K, et al.Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines[J]. Support Care Cancer, 2020, 28(5):2449-2456. DOI:10.1007/s00520-019-05217-x. [15] Elad S, Cheng KKF, Lalla RV, et al.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy[J]. Cancer, 2020, 126(19): 4423-4431. DOI:10.1002/cncr.33100. [16] Logan RM, Al-Azri AR, Bossi P, et al.Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines[J]. Support Care Cancer, 2020, 28(5):2485-2498. DOI:10.1007/s00520-019-05170-9. [17] 马婷婷, 吴琼, 欧阳静, 等. 中国癌症症状管理实践指南—口腔黏膜炎[J]. 护士进修杂志, 2020, 35(Issue): 1871-1878. DOI:10.16821/j.cnki.hsjx.2020.25.028. [18] Robert SN,Joseph AT.Oral toxicity associated with chemotherapy[EB/OL]. (2021-06-04)[2021-06-22]. http://uptodate.0005.a.isus.top/contents/oral-toxicity-associated-with-chemotherapy?search=Oral%20toxicity%20associated%20with%20chemotherapy&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. [19] Supportive Palliative Care Editorial Board. Oral complications of chemotherapy and head/neck radiation (PDQ®): health professional version[M]. Bethesda: National Cancer Institute, 2016. [20] Whitehorn A. Oral mucositis: assessment [EB/OL]. (2021-04-06)[2021-05-24].http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&AN=JBI15067. [21] Whitehorn A. Oral mucositis: prevention and management principles [EB/OL].(2021-04-09)[2021-05-24].http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&AN=JBI966. [22] Lizarondo L. Hematopoietic stem cell transplantation: oral care [EB/OL].(2021-05-04)[2021-05-24].http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=jbi&NEWS=N&AN=JBI110772. [23] Botti S,Cecco V,Galgano L, et al.Oral mucositis in hematopoietic stem cell transplantation (HSCT): position statement by Gruppo Italiano Trapianto Di Midollo Osseo(GITMO) Nurses Group[J]. Drug and Cell Therapy in Hematology, 2014, 4:205-223. [24] 中华医学会放射肿瘤治疗学分会. 放射性口腔黏膜炎防治策略专家共识(2019)[J]. 中华放射肿瘤学杂志, 2019,28(9):641-647. DOI:10.3760/cma.j.issn.1004-4221.2019.09.001. [25] 中国临床肿瘤学会抗肿瘤药物安全管理专家委员会, 中国临床肿瘤学会肿瘤支持与康复治疗专家委员会. 抗肿瘤治疗引起急性口腔黏膜炎的诊断和防治专家共识[J]. 临床肿瘤学杂志,2021,26(5):449-459. DOI:10.3969/j.issn.1009-0460.2021.05.011. [26] Hosseinjani H, Hadjibabaie M, Gholami K, et al.The efficacy of erythropoietin mouthwash in prevention of oral mucositis in patients undergoing autologous hematopoietic SCT: a double-blind, randomized, placebo-controlled trial[J]. Hematol Oncol,2017,35(1):106-112.DOI:10.1002/hon.2250. [27] Salvador DRN, Soave DF, Sacono NT, et al.Effect of photobiomodulation therapy on reducing the chemo-induced oral mucositis severity and on salivary levels of CXCL8/interleukin 8, nitrite, and myeloperoxidase in patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial[J]. Lasers Med Sci, 2017, 32(8): 1801-1810. DOI:10.1007/s10103-017-2263-1. [28] Keefe DM, Schubert MM, Elting LS, et al.Updated clinical practice guidelines for the prevention and treatment of mucositis[J]. Cancer, 2007, 109(5):820-831. DOI:10.1002/cncr.22484. [29] Hensley ML, Hagerty KL, Kewalramani T, et al.American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants[J]. J Clin Oncol, 2009, 27(1):127-145. DOI:10.1200/jco.2008.17.2627. [30] Lalla RV, Bowen J, Barasch A, et al.MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy[J]. Cancer, 2014, 120(10): 1453-1461. DOI:10.1002/cncr.28592. [31] Hong CH, Napeñas J J, Hodgson BD, et al.A systematic review of dental disease in patients undergoing cancer therapy[J]. Support Care Cancer, 2010, 18(8):1007-1021. DOI:10.1007/s00520-010-0873-2. [32] Worthington HV, Clarkson JE, Bryan G, et al. Interventions for preventing oral mucositis for patients with cancer receiving treatment[J].Cochrane Database Syst Rev, 2010, 12(4): Cd000978. DOI:10.1002/14651858.CD000978.pub3. [33] Riley P, Glenny AM, Worthington HV, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors[J]. Cochrane Database Syst Rev, 2017, 11(11):Cd011990. DOI:10.1002/14651858.CD011990.pub2. [34] Mori T, Yamazaki R, Aisa Y, et al.Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients[J]. Support Care Cancer, 2006, 14(4):392-395. DOI:10.1007/s00520-005-0016-3. |
| [1] | SHEN Xin-yi, LI Rong-rong, CHAN Yu-ying, ZHANG Guan-xun, YANG Qi, ZHANG Lin. Symptom Clusters and Sentinel Symptoms of Children with Acute Lymphoblastic Leukemia during Maintenance Chemotherapy [J]. Journal of Nursing, 2022, 29(15): 59-64. |
| [2] | RUAN Hai-tao, ZHANG Zi-yi, ZHOU Li, XU Li. Nursing of Leukemia Patients Undergoing Chimeric Antigen Receptor T-cell Therapy with Severe Neurotoxicity: A 2-case Study [J]. Journal of Nursing, 2022, 29(12): 67-69. |
| [3] | YAO jing-jing, LIU Ying, XU Hui-juan, SUN Si-min, CHEN Min, JIANG Xue-jie. Prevention and Management of Chemotherapy-induced Constipation in Patients with Acute Leukemia: A Evidence-based Nursing Practice Project [J]. Journal of Nursing, 2022, 29(8): 40-45. |
| [4] | LUO Yu-qin, LI Meng-xuan, CHENG Qiu, WANG Ting, ZHENG Jing-yu, FANG Jin-bo, GONG Yu-ping. Case-control Study on Risk Factors of Perianal Infection in Patients with Hematological Malignancy undergoing Chemotherapy [J]. Journal of Nursing, 2022, 29(7): 7-11. |
| [5] | . [J]. Journal of Nursing, 2021, 28(19): 52-58. |
| [6] | WU Xiao-heng, YANG Yuan-li, HU Xin-yu, WANG Cui-ping, ZHANG Ying, WANG Yan-chun, TAO Yan-ling. Evidence-based Practice in Process Management of Blood Transfusion in Inpatients [J]. Journal of Nursing, 2021, 28(8): 33-38. |
| [7] | . [J]. Journal of Nursing, 2021, 28(1): 62-63. |
| [8] | YANG Bei-bei, TONG Xin-yang, CHEN Fang, WANG Xiao-mei, LI Ling, LI Li-yan, WAN Feng-jing. Consistency of Self-report and Nursing Records of Adverse Reactions in Children with Leukemia: A 60-case Study [J]. Journal of Nursing, 2020, 27(17): 67-72. |
| [9] | . [J]. Journal of Nursing, 2020, 27(14): 30-34. |
| [10] | . [J]. Journal of Nursing, 2019, 26(19): 63-65. |
| [11] | . [J]. Journal of Nursing, 2019, 26(3): 56-58. |
| [12] | XIE Wen-jun, ZHANG Shuai, LIU Yi, ZHANG Hui-juan, LIU Gui-ying, WANG Bei, LIU Jie, LIU Yu-qiu, GUAN Wei. Perceived Social Support and Coping Style as Mediators between Resilience and Post-traumatic Growth among Patients with Hematopoietic Stem Cell Transplant [J]. Journal of Nursing, 2019, 26(3): 73-78. |
| [13] | . [J]. Journal of Nursing, 2018, 25(21): 19-23. |
| [14] | . [J]. Journal of Nursing, 2019, 26(14): 38-42. |
| [15] | . [J]. Journal of Nursing, 2019, 26(14): 63-65. |
|